Art

J-GLOBAL ID：202002289104686025   Reference number：20A2576923

Connecting Alzheimer’s Disease With Diabetes Mellitus Through Amyloidogenic Evolvability

アミロイド形成進化可能性による糖尿病とAlzheimer病との接続【JST・京大機械翻訳】

Author (8)： Ho Gilbert (PCND Neuroscience Research Institute, Poway, CA, United States) ,  Takamatsu Yoshiki (Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan) ,  Wada Ryoko (Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan) ,  Sugama Shuei (Department of Physiology, Nippon Medical School, Tokyo, Japan) ,  Waragai Masaaki (PCND Neuroscience Research Institute, Poway, CA, United States) ,  Takenouchi Takato (Institute of Agrobiological Sciences, National Agriculture and Food Research Organization, Tsukuba, Japan) ,  Masliah Eliezer (Division of Neurosciences, National Institute on Aging, National Institutes of Health, Bethesda, MD, United States) ,  Hashimoto Makoto (Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan)
Material： Frontiers in Aging Neuroscience (Web)
Volume： 12  Page： 576192  Publication year： 2020 
JST Material Number： U7056A  ISSN： 1663-4365  Document type： Article
Article type： 原著論文  Country of issue： Switzerland (CHE)  Language： ENGLISH (EN)

Abstract/Point： Type 2 diabetes mellitus (T2DM...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A2576923&from=J-GLOBAL&jstjournalNo=U7056A") }}

Thesaurus term： interaction ,  *Diabetes Mellitus ,  senile change ,  targeting ,  Amyloidosis ,  *Alzheimer Disease ,  type 1 diabetes mellitus ,  Type 2 diabetes mellitus ,  oxidative stress ,  pathogenesis ,  Adiponectin ,  amyloid beta-protein ,  Islet Amyloid Polypeptide ,  stressor ,  *amyloid formation ,  Amyloid ,  glycoprotein ,  animal protein

Author keywords (5)： Alzheimer’s disease ,  diabetes mellitus ,  evolvability ,  antagonistic pleiotropy ,  adiponectin paradox

JST classification (2)： Nervous system diseases  (GN03000O) ,  Metabolic diseases,nutritional diseases in general.  (GD05010J)

Reference (79)：

• AbediniA.SchmidtA. M. (2013). Mechanisms of islet amyloidosis toxicity in type 2 diabetes. FEBS Lett. 587, 1119-1127. doi: 10.1016/j.febslet.2013.01.01723337872
• AkterR.CaoP.NoorH.RidgwayZ.TuL. H.WangH.. (2016). Islet amyloid polypeptide: structure, function, and pathophysiology. J. Diabetes Res. 2016:2798269. doi: 10.2210/pdb5e61/pdb26649319
• AthaudaD.MaclaganK.SkeneS. S.Bajwa-JosephM.LetchfordD.ChowdhuryK.. (2017). Exenatide once weekly versus placebo in Parkinson’s disease: a randomised, double-blind, placebo-controlled trial. Lancet 390, 1664-1675. doi: 10.1016/S0140-6736(17)31585-428781108
• AtlantisE.FaheyP.FosterJ. (2014). Collaborative care for comorbid depression and diabetes: a systematic review and meta-analysis. BMJ Open 4:e004706. doi: 10.1136/bmjopen-2013-00470624727428
• Aviles-OlmosI.LimousinP.LeesA.FoltynieT. (2013). Parkinson’s disease, insulin resistance and novel agents of neuroprotection. Brain 136, 374-384. doi: 10.1093/brain/aws00922344583

Terms in the title (5)： アミロイド形成 ,  進化 ,  可能性 ,  糖尿病 ,  Alzheimer病